732 followers
#CPX351 in #FLT3-mutated acute myeloid leukemia https://t.co/FfZ9lYiT3v #leusm @AML_Hub https://t.co/EqjRyyyOQt
#CPX351 in #FLT3-mutated acute myeloid leukemia https://t.co/FfZ9lYiT3v #leusm @AML_Hub https://t.co/EqjRyyyOQt
CPX-351 in FLT3 mutated acute myeloid leukemia. https://t.co/OOtxIQkJwS
New research: CPX-351 in FLT3-mutated acute myeloid leukemia: CPX-351, a dual-drug liposomal encapsulation of daunorubicin and cytarabine in a 1:5 molar ratio, is approved for the treatment of newly diagnosed therapy-related acute myeloid… https://t.co/r6K